BGI Genomics Co., Ltd. is a low-risk Pharmaceuticals company based in China. Specializing in genomic research and diagnostic services, BGI Genomics uses biotechnology to deliver high-quality services in various fields including agriculture, cancer research, and drug discovery. With a strong focus on ESG principles, the company serves academic institutions, hospitals, and medical facilities both in China and internationally.